FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5                       
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Bruneau Aure
2. Issuer Name and Ticker or Trading Symbol

ZIMMER BIOMET HOLDINGS, INC. [ ZBH ]
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                    _____ 10% Owner
__X__ Officer (give title below)    _____ Other (specify below)
Group President
(Last)          (First)          (Middle)

C/O ZIMMER, INC., P. O. BOX 708
3. Date of Earliest Transaction (MM/DD/YYYY)

11/11/2019
(Street)

WARSAW, IN 46580
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 11/11/2019  M  3150 A$113.83 3907 D 
 
Common Stock 11/11/2019  S  3150 D$141.306 (1)757 D 
 
Common Stock 11/11/2019  M  4718 A$104.01 5475 D 
 
Common Stock 11/11/2019  S  4718 D$141.243 (2)757 D 
 
Common Stock 11/11/2019  M  1613 A$103.25 2370 D 
 
Common Stock 11/11/2019  S  1613 D$141.475 (3)757 D 
 
Common Stock 11/11/2019  M  2910 A$121.88 3667 D 
 
Common Stock 11/11/2019  S  2910 D$141.168 (4)757 D 
 
Common Stock 11/11/2019  M  2780 A$114.44 3537 D 
 
Common Stock 11/11/2019  S  2780 D$141.14 (5)757 D 
 

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security3. Trans. Date3A. Deemed Execution Date, if any4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Employee Stock Option (right to buy) $113.83 11/11/2019  M     3150   (6)6/24/2025 Common Stock 3150 $0 0 D 
 
Employee Stock Option (right to buy) $104.01 11/11/2019  M     4718   (7)3/21/2026 Common Stock 4718 $0 1572 D 
 
Employee Stock Option (right to buy) $103.25 11/11/2019  M     1613   (8)1/3/2027 Common Stock 1613 $0 1612 D 
 
Employee Stock Option (right to buy) $121.88 11/11/2019  M     2910   (9)3/21/2027 Common Stock 2910 $0 2910 D 
 
Employee Stock Option (right to buy) $114.44 11/11/2019  M     2780   (10)3/20/2028 Common Stock 2780 $0 8340 D 
 

Explanation of Responses:
(1) Represents the sale of 3,150 shares in multiple transactions ranging in price from $140.98 to $141.595 per share, resulting in a weighted average sale price of $141.306. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price within the range.
(2) Represents the sale of 4,718 shares in multiple transactions ranging in price from $141.005 to $141.64 per share, resulting in a weighted average sale price of $141.243. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price within the range.
(3) Represents the sale of 1,613 shares in multiple transactions ranging in price from $141.00 to $141.72 per share, resulting in a weighted average sale price of $141.475. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price within the range.
(4) Represents the sale of 2,910 shares in multiple transactions ranging in price from $141.065 to $141.505 per share, resulting in a weighted average sale price of $141.168. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price within the range.
(5) Represents the sale of 2,780 shares in multiple transactions ranging in price from $140.995 to $141.59 per share, resulting in a weighted average sale price of $141.14. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price within the range.
(6) One-fourth of the options vested on each of June 24, 2016, June 24, 2017, June 24, 2018 and June 24, 2019.
(7) 4,718 of the options vested in thirds on each of March 21, 2017, March 21, 2018 and March 21, 2019; and the remaining unvested options will vest on March 21, 2020.
(8) 806 options vested on January 3, 2018; 807 options vested on January 3, 2019; and the remaining unvested options will vest in equal portions on each of January 3, 2020 and January 3, 2021.
(9) 1,455 options vested on each of March 21, 2018 and March 21, 2019; and the remaining unvested options will vest in equal portions on each of March 21, 2020 and March 21, 2021.
(10) 2,780 options vested on March 20, 2019; and the remaining unvested options will vest in equal portions on each of March 20, 2020, March 20, 2021 and March 20, 2022.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director10% OwnerOfficerOther
Bruneau Aure
C/O ZIMMER, INC.
P. O. BOX 708
WARSAW, IN 46580


Group President

Signatures
/s/ Heather J. Kidwell, Attorney-in-Fact for Aure Bruneau (power of attorney previously filed)11/13/2019
**Signature of Reporting PersonDate

Zimmer Biomet (NYSE:ZBH)
Historical Stock Chart
From Aug 2024 to Sep 2024 Click Here for more Zimmer Biomet Charts.
Zimmer Biomet (NYSE:ZBH)
Historical Stock Chart
From Sep 2023 to Sep 2024 Click Here for more Zimmer Biomet Charts.